Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 2 | MIP-1A | 23.0 | 57 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | MIP-1A | 23.5 | 52 | ||||
RA2708 | 2 | MIP-1A | 23.0 | 56 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 51.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 58.0 | 50 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 41.0 | 54 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 51.0 | 45 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 49.0 | 51 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 47.0 | 47 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 58.0 | 60 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 68.5 | 62 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 42.0 | 42 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 49.5 | 56 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MIP-1A | 52.0 | 40 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MIP-1A | 50.0 | 41 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 24.0 | 58 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 28.0 | 54 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 24.0 | 50 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 22.0 | 47 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 25.0 | 51 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 30.0 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 88.0 | 52 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 68.0 | 59 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 24.0 | 44 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MIP-1A | 29.0 | 54 |